Home News Annual Report of Office of Generic Drugs 2022

Annual Report of Office of Generic Drugs 2022


FDA’s Office of Generic Drugs issued their 2022 Annual Report. Generic drugs are vital in saving payers and patients money. For example, pregabalin pills cost $450 for 30-day supply after its market exclusivity ended. But the price dropped to $23 (a 95% reduction) in the first 12 month following generic entry. This drug alone saved the healthcare system $6.6 billion. Generic sales saw a 95% price drop in the first 12 months.

The Office of Generic Drugs approved 106 of the first generic drugs in 2022. Here are some highlights of the report.

Continue reading…

Previous articleHow to prepare for data disruption in the healthcare industry
Next articleFootball concussions tied to long-term cognitive problems